Evidence map›Paper›PMID 35074300›Full record

ArticleNephrologie & therapeutique2022

[Leukocytoclastic vasculitis and acute renal failure following inactivated SARS-CoV-2 vaccine].

Soumia Missoum, Mourad Lahmar, Ghalia Khellaf

Open access · greenAbstract readCase Reports
In one paragraph

Article in Nephrologie & therapeutique, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Soumia MissoumDépartement de médecine, université de Batna, route de Constantine Fesdis, Batna, Algérie; Service de néphrologie, CHU Benflis Touhami, route de Tazoult, Batna, Algérie. Electronic address: soumia_missoum@outlook.fr.
Mourad LahmarDépartement de médecine, université de Batna, route de Constantine Fesdis, Batna, Algérie; Service d'anesthésie réanimation, CAC, route de Tazoult, Batna, Algérie.
Ghalia KhellafDépartement de médecine, université d'Alger, 02, rue Ahmed Ouaked Dely Ibrahim, Alger, Algérie; Service de néphrologie, CHU Lamine Debaghinel, Saint-Eugene Beb El Oued, Alger, Algérie.
University of Batna 1 · DZCentre Hospitalo-Universitaire Bab El Oued · DZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 vaccines are being administered worldwide. Most side effects are mild and self-limiting with few reported cases of severe reactions. We report a case of leukocytoclastic vasculitis with acute kidney failure following aninactivated SARS-CoV-2 vaccine, unique for its dramatic visual presentation and its rapid response to treatment. This is the case of a 58years-old man presenting with fever, arthralgias and vascular purpura on his limbs associated with acute kidney failure requiring hemodialysis nine days after anti-COVID-19 vaccination. Skin biopsy revealed a leukocytoclastic vasculitis and a renal biopsy showed an acute tubulointerstitial nephritis. The vascular purpura resolved 7days after initiating treatment with prednisone but the patient remains in chronic renal failure. The analysis and investigation of the complications and adverse events induced by anti-COVID-19 vaccines could increase our understanding of the underlying pathogenesis.

Indexed as

Acute Kidney InjuryCOVID-19COVID-19 VaccinesHumansIgA VasculitisMaleSARS-CoV-2Vasculitis, Leukocytoclastic, CutaneousCOVID-19 VaccinesAcute interstitial nephritisCOVID-19 vaccineLeukocytoclastic vasculitisNéphrite interstitielle aiguëVaccin COVID-19Vascularite leucocytoclasique

Identifiers

PMID35074300
PMCPMC8651508
OpenAlexW4200555910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.